Montreal, Canada - August 27, 2024: Hexoskin, a Montreal-based digital health and AI company developing medical-grade wearables and algorithms for health monitoring and diagnostics, is very excited to announce today an additional USD $4.2M capital raise to invest in growth, digital biomarkers research, and new AI-based digital diagnostics solutions. Investors include AQC Capital and Anges Quebec (Canada), BDC Capital (Canada), ballas invest (Europe), Deep Divers Ltd (UK), and 19 other US and Canadian private investors.
Pierre-Alexandre Fournier, Hexoskin’s CEO, commented: “Hexoskin’s team has over 15 years of experience in clinical AI development and high-resolution wearable sensors. Our investors understand how our digital platform is uniquely positioned to develop a range of diagnostic tests and digital solutions that can address the needs of large populations in disease areas with large unmet needs, such as cardiac, respiratory and rare diseases.”
Hexoskin's current wearable sensing products (Hexoskin & Astroskin) serve the clinical research, defense, and aerospace markets. Its customers, including CSA, NASA, DOD, Yale Health, Boston Children's Hospital, and hundreds of research teams across the world, have published over 250 scientific papers with Hexoskin data. Hexoskin smart shirts are also used in pharma clinical trials, and its technology has been part of the International Space Station since 2019 to support clinical trials in space.
"We are excited to team up with Hexoskin and its investors to enable its next phase of development globally" said Laurent van Lerberghe, Co-Founder of ballas invest and former Chief Strategy Officer at Sanofi. "We have been impressed by the wealth of expertise accumulated by Hexoskin with trillions of data points, more than a hundred clinical trials, and over 250 peer-reviewed publications. Through novel higher resolution digital measures and digital biomarkers in clinical and real-world settings, Hexoskin is unlocking the possibilities of early disease detection, high quality monitoring, hence improving treatment decisions and patients’ quality of life".
Hexoskin’s software and wearable sensor products are used by clinical research teams around the world to collect digital endpoints in patient populations for a wide range of health conditions: cardiac (arrhythmias, heart rate variability), respiratory (CODP, asthma), cancer, neuro (dementia, epilepsy), rare diseases and pediatric research (Rett syndrome, ME/CFS, Long Covid).
"This additional equity funding allows us to better serve the scientific and medical communities," added Fournier. "Patients, healthcare providers, and researchers are looking for products that are accurate, validated in diverse populations, and easy to use to collect clinical data in real-world settings. Hexoskin’s solutions accomplish these goals, offering high-quality and reliable tools to improve patient outcomes through research and clinical care. Expanding our investor base from Canada to US and Europe is a clear marker of our global potential."
About Hexoskin
Hexoskin (Carré Technologies Inc.) is a pioneer in continuous, passive remote health monitoring driven by AI. Hexoskin's platform and technology are used by hundreds of institutional partners for research purposes, in studies examining breathing disorders, cardiac and pulmonary diseases, rare diseases, stress, sleep, epilepsy, and other conditions. If you're interested in investing in Hexoskin please consult our investor relations section.
An End-to-End Solution for Clinical Research
Launched in 2023, the company’s new clinical development software platform, Hexoskin OneView, allows research teams to follow cohorts of participants as the complete clinical protocols, monitoring compliance and data quality. The platform is used today to collect data for new clinical AI algorithms for diagnostics and quality of life assessments. The data captured include heart rhythms and ECG, breathing patterns, PPG/SpO2, blood pressure, temperature, activity, and patient-reported outcomes with standardized questionnaires or symptoms reporting.
From Space Medicine to Ivy League Research
Hexoskin's current wearable products (Hexoskin and Astroskin) serve the clinical research, defense, and aerospace markets. Its customers, including NASA, DOD, Yale Health, Boston Children's Hospital, Columbia University, and hundreds of researchers and hospitals, have published over 250 scientific papers with Hexoskin data. Hexoskin smart shirts are used in pharmaceutical clinical trials, and its technology has been part of the International Space Station since 2018.
Mayo Clinic Accelerator Program
Hexoskin has been selected by Mayo Clinic in 2019 for their MedTech accelerator program and is currently implementing remote patient monitoring programs in cardiology and pulmonology with health systems in the US and Canada.
Hexoskin’s Unique Database
Over the past 10 years, Hexoskin has built the largest ambulatory cardio-respiratory database in the world. The database includes hundreds of millions of breathing patterns and billions of cardiac rhythm patterns, in addition to sleep data and annotations specific to many other health conditions, developed with hospitals and research partners in the US, Canada and Europe. The company leverages its proprietary database to develop new AI-based digital diagnostic solutions.
Pediatric Research
Hexoskin is one of few companies that have made available wearable sensing solutions for pediatric research. The Hexoskin Junior biometric shirt is used by research groups to study sleep patterns, respiratory health, and rare diseases in children 3 to 17 years old.
Today we attended the 6th session of HITLAB's BT1 Virtual Knowledge Convene to discuss "The Impact of Wearable Technology on Digital Diagnostics". This was an opportunity to talk and discuss about the past, present, and future of medical wearables with Columbia University's HITLAB international community.
A few of the topics we covered:
• How wearables are revolutionizing healthcare data collection
• The potential of wearables for early disease detection and remote patient monitoring
• The future of personalized medicine powered by wearable tech.
This week Hexoskin was participating in HITLAB's New York City Health Innovation Week in Manhattan. The event was attended by dozens of startups and large life science companies such as Merck, Novo Nordisk, and Sanofi.
To learn more about Hexoskin's involvement in pharma trials and clinical research, please write us at: contact@hexoskin.com
The UNOOSA (United Nations Office of Outer Space Affairs) has invited Hexoskin's CEO Pierre-Alexandre Fournier to speak about medical research conducted aboard the International Space Station with Astroskin wearable sensors.
The webinar entitled "From Space to Earth: Innovations enabling accessibility on Earth" was live on Thursday November 9th, 2023, you watch a recording of the event here.
There are less than 700 astronauts who have visited space from the time Yuri Gagarin reached orbit for the first time in 1961 to now in 2023. Most of these astronauts were selected to have none or few health conditions.
With space more accessible than ever, we expect thousands of people to visit space in the coming decades on suborbital and orbital flights. Many of these new astronauts who will visit space to work or as travellers will have health conditions or disabilities.
Health research conducted in the space station today with Astroskin health sensors helps better understand the risks and mitigation strategies to make space more accessible. It also helps better understand the effects of aging on human performance: microgravity has effects on the cardiovascular and musculoskeletal systems analog to accelerated aging.
About the UNOOSA
The United Nations Office for Outer Space Affairs (UNOOSA) works to promote international cooperation in the peaceful use and exploration of space, and in the utilisation of space science and technology for sustainable economic and social development. The Office assists any United Nations Member States to establish legal and regulatory frameworks to govern space activities and strengthens the capacity of developing countries to use space science technology and applications for development by helping to integrate space capabilities into national development programmes.
Kellie Gerardie, a U.S. Payload Specialist and Bioastronautics Researcher for the International Institute for Astronautical Sciences (IIAS), will become this week the first astronaut to use the Astroskin wearable vital signs monitoring system on a suborbital flight.
This is an important milestone for the Astroskin research platform, because the wearable sensors will be worn for the first time during a whole mission: launch, adaptation to microgravity, and landing.
This will allow the IIAS to collect physiological data during critical stages of the spaceflight: from rest to 3g acceleration and then microgravity, an astronaut's body experience stress and needs to adapt to the constant changing environment while the Virgin Galactic's VSS Unity spaceship leaves New Mexico for space and comes back. These changes can be measured using Astroskin's wearable sensors.
The Galactic 05 research mission spaceflight is scheduled to launch on November 2nd 2023 from Spaceport America, 32 km southeast of the city of Trust or Consequences, New Mexico.
The Bio-Monitor Astroskin system is used aboard the International Space Station since 2019 to conduct medical research on the effects of spaceflight on human physiology. Four research projects are currently ongoing, mostly focusing on the cardiovascular and respiratory systems. Its deployment in space has been funded by the Canadian Space Agency and the system has been used by astronauts from CSA, NASA, ESA, JAXA, and the UAE Space Agency.
Over the years, Astroskin has become a standard for complex, continuous vital signs monitoring for space research. The system was awarded the 2022 International Space Station Research Innovation Award for Human Health in Space by the American Astronautical Society.
Kellie Gerardie has been training with the Astroskin to collect baseline data for over a year. The use of Astroskin before, during, and after the flight will be supported the IIAS payload integration team: Yvette Gonzalez, Dr Shawna Pandya, and Dr Aaron Persad.
Read more about Astroskin wearable sensors: https://hexoskin.com/astroskin
Read more about the Galactic 05 mission space research program here.
Since the late 19th century, modern research on human performance has led to the study of cognitive abilities, physiological, and psychological factors that influence human capabilities.
Although significant pioneering efforts have been made in the 20th century and in recent decades, there are still several unexplored research areas that could potentially enhance the resilience and health of military personnel and warfighters. Key areas include understanding the neuroscience of performance, human-technology interaction, performance in extreme environments, individual variability, collaborative performance, and ethical approaches to performance enhancement. Additionally, long-term skill development, cross-disciplinary research, non-traditional performance metrics, and performance in virtual environments hold untapped potential for transformative discoveries.
Top institutions such as the U.S. Navy Naval Research Center (USA), the Canadian Armed Forces, and the French Armed Forces Biomedical Research Institute (IRBA) (France), are at the forefront of state-of-the-art studies pertaining to human performance, readiness, stress, fatigue, and fitness. Leveraging the Hexoskin and Astroskin smart garments with embedded health sensors and an end-to-end platform providing continuous health status and high-resolution data, these organizations are paving the way for deeper understanding and advancements in the fields of human physiology and performance optimization. From assessing the endurance, physical fitness and resilience of warfighters to unraveling the mysteries of physiological responses, their efforts promise to reshape our comprehension of human potential, enhancing readiness, and fostering safer and more effective operational environments.
One of the organizations leading the charge includes the team at the U.S. Naval Health Research Center located in San Diego that aims to improve the health, well-being, and performance of the United States military personnel and veterans. Their research revolves around monitoring and enhancing Warfighter performance and operational readiness through the integration of physical and cognitive monitoring.
The team at Naval Health Research Center uses cutting-edge wearable biometric sensors, including Hexoskin and Astroskin devices, to measure vital signs such as ECG, heart rate, oxygen saturation, and breathing rate in real-time and other important stress, fatigue, cognitive, and performance markers with heart rate variability (HRV). In their facilities that include simulation labs, driving simulators, and virtual reality (VR) environments, they are validating the accuracy and effectiveness of Hexoskin and Astroskin by comparing them with gold standard measurements. Their goal is to integrate solutions like Hexoskin & Astroskin with custom virtual reality programs and other research tools for comprehensive data analysis. The data collected will help them perform stress levels assessments, fatigue, and overall performance, leading to personalized training plans and strategies for stress and fatigue management for deployment in real-world scenarios.
Source: Astroskin Webinar: Amy Silder, PhD. Biomonitoring in Warfighter Performance
The Canadian Armed Forces (CAF) studied the performance and reliability of the Hexoskin garment. A Canadian Forces Health Services Group reserve unit used the Hexoskin garment during a two-day military field exercise that included reconnaissance, reacting to enemy fire, and providing tactical field care to casualties.
The final exercise was conducted over two nights and three days in moderate weather conditions in British Columbia, Canada.
Hexoskin was found to be comfortable during various environmental and weather conditions while continuously collecting cardiac, respiratory, activity, and sleep data.
Another innovative project with Astroskin is led by the Agence Innovation Defense under the Ministère des Armées in France. The SPEEN project aims to monitor pilots during flights, measuring their real-time health parameters including blood oxygen levels with the Astroskin SpO2 pulse oximeter. The project aims to alert pilots of unnoticed situations and predict critical conditions using artificial intelligence. Conceived by Ship-of-the-line lieutenant Christophe and supported by Frigate Captain Gautier, both test pilots at the Centre d'expérimentations pratiques et de réception de l'aéronautique navale (CEPA). The research involving Astroskin has been conducted in partnership with the Institut de Recherche Biomédicale des Armées (IRBA), the Département de Médecine Aéronautique Opérationnelle (DMAO), Hexoskin and Knopé, Hexoskin's Distributor in France.
Source: Agence Innovation Défense
Thanks to their efforts and for enhancing flight safety by understanding and predicting unexplained physiological events during flight through individual data and AI, the team received the Prix de l'audace award given by the Ministère des Armées in 2022.
By tracing new paths in human performance research and innovative technology applications, these efforts can support not only the resilience and well-being of active military personnel and warfighters but also provide better support and care to veterans, and beyond.
These groundbreaking studies and projects can also extend to the lives of veterans who transition to civilian life. As we refine our understanding of stress, fatigue, and resilience, the impact of the work accomplished can influence how we approach healthcare and well-being services to improve the quality of life of active personnel and our retired service members.
As we navigate unexplored frontiers, the journey extends beyond the laboratory and battlefield, shaping a future where the dedication of our armed forces is met with a reciprocal commitment to their lifelong health and success.
Contact Hexoskin today to discuss how the Hexoskin & Astroskin end-to-end platform can support your projects.
In the rapidly evolving landscape of health research, the integration of cutting-edge technologies has become paramount for advancing scientific exploration and discovery. The pursuit of innovative methodologies and tools to enhance the precision and scope of health research is a shared concern for academic institutions and researchers worldwide.
Each new research or discovery presents a set of constraints and challenges that researchers and students must go through to secure funding, navigate Institutional Review Boards and Ethics committees and recruit and retain participants, while balancing schedules and pressure to publish. Additionally, obtaining access to specialized equipment and generating high-quality data, sometimes across multiple facilities, can incur significant costs and time commitments. The need for accessible solutions that support researchers and students in their data collection, analysis and interpretation has emerged as a pivotal requirement for universities aspiring to position their institution as top research and innovation hubs on the national and global stage.
This is why leading research institutions including McGill University, Alma College, Salzburg University, TELUQ, The University of Arizona, and the University of Alberta, to name a few, have embraced cutting-edge technologies like Hexoskin and Astroskin as integral components of their laboratory equipment & research methodologies to conduct their projects thanks to their relative lower costs for collecting multiparameters high-resolution data and advanced study management and analytics tools.
An illustrative example of an academic institution's commitment to supporting its research community is the University of Arizona's SensorLab. Funded by the University of Arizona Strategic Plan, SensorLab is a Health Sciences initiative bringing students, faculty, industry and community partners together to pioneer human-centered sensor systems. The laboratory connects researchers across disciplines, within health sciences and beyond, to develop a range of health-oriented technologies and digital solutions, including AI, VR, and mobile apps. SensorLab is outfitted with gold-standard and state-of-the-art sensor systems like Hexoskin, environmental monitoring, 360 video and audio recording, XR, coupled with analytical tools and multimodal feedback capabilities to push forward the next generation of sensor-based investigation and discovery.
For students, SensorLab provides two key services: lending equipment and sensors for shared use, as well as dedicated research spaces configured for sensor-based projects. Students can engage at varying levels, from borrowing hardware to actively contributing to the design and development of sensor-driven research.
Over the years, Hexoskin has made it easier for research clients and developers to leverage fully the Hexoskin and Astroskin platform and collaborate on premises and remotely. Research groups such as the team behind the WE SENSE study at McGill University can answer research questions and hypothesis by leveraging the additional sensors provided with Astroskin or Hexoskin to determine the health parameters and metrics that are most relevant to answer their research questions and build their models. Given that Hexoskin and Astroskin offer processed and raw data in multiple formats suitable for advanced analysis, researchers are leveraging the online dashboard and API to extract the data to work on their models using machine learning and artificial intelligence methods.
Other research groups like at Salzburg University are going further in their experimentations by leveraging the SDK tools available to developers for Hexoskin and Astroskin to access the raw data in real time enabling them to build ground breaking apps while also leveraging the data collected in their research to publish scientific papers.
With a presence in over 50 countries and growing, Hexoskin & Astroskin have been adopted and shared across organizations and labs to conduct and deliver projects.
Contact Hexoskin today to discuss how the Hexoskin & Astroskin end-to-end platform can support your projects.
Sultan Al Neyadi is an Emirati astronaut and one of the first two astronauts from the United Arab Emirates, along with Hazza Al Mansouri. As part of Expedition 69, he's participating in the longest Arab space mission in history!
Sultan Al Neyadi was launched into orbit February 26th, 2023 aboard SpaceX's Crew-6 mission, which was also carrying Astroskin resupply payload. He's involved in hundreds of scientific activities including 19 major scientific experiments for the UAE.
One of these experiments involves measuring his vital signs in the ISS space environment using the Bio-Monitor Astroskin wearable sensors system.
What I'm wearing isn't just any shirt. The Bio-Monitor smart shirt & headband I have on tracks vital health stats such as heart rate, blood pressure & more offering insights into our body's response to microgravity. This technology can be a game-changer for remote healthcare.🩺🔬 pic.twitter.com/e6YHC975kK
— Sultan AlNeyadi (@Astro_Alneyadi) May 31, 2023
The Astroskin Bio-Monitor system first reached the International Space Station in December 2018, and has been commissionned by Canadian astronaut David Saint-Jacques in January 2019. The wearable vital signs monitoring system has since been used by astronauts to participate in one of the many ongoing research projects on human physiology in microgravity using the platform.
Astroskin is also used by hundreds of researchers on Earth to push the boundaries of medical knowledge.
Here's a list of space launches that carried Astroskin payloads as of June 2023:
The Canadian Space Agency (CSA) has awarded contracts to five teams to build prototypes of the Connected Care Medical Module (C²M²), a container-based concept for mobile medical clinics that can be rapidly deployed in remote, northern, or indigenous communities across Canada, in regions affected by natural disasters, and in future lunar and deep space missions.
Hexoskin (Carré Technologies Inc.) is proud to be part of the HARMONY team, led by CGI, one of the largest IT firms in the world, along with OKAKI Health Intelligence, PrecisionOS Technology, 12Volt: Games Studio, and Dr. Carolyn McGregor of the University of Ontario Institute of Technology.
Hexoskin will contribute Astroskin devices and AI-based medical software to the project. A first demonstration is planned for June 2023.
Health Beyond's vision is to enable agile, rapid prototyping and iterative operation of C²M²s on Earth, with the ultimate objective of operation in space. A C²M² is a scalable integrated system of state-of-the-art medical technologies and methodologies contained in a deployable unit. A shipping container will first be used for research and development purposes and for easy deployment across Canada via the existing intermodal freight transportation network. When preparing for space application and deployment in remote communities with collaborators, the medical module can be scaled down and adapted as needed.
One of the novel features of the C²M² is its core computer-based system that facilitates the incorporation, interconnection (i.e., flow of information), and usage of the latest medical technologies. This plug and play architecture will enable multiple configurations based on the end users' needs. These technologies increase the user's capacity to independently detect, diagnose, treat, and/or monitor health conditions on site. This improves the timeliness, quality, and continuity of care; refines clinical decision-making; and reduces the occurrence of risky and expensive medical transportation of patients from remote regions to urban hospital facilities.
(photo: Canadian Space Agency)
What if you could combat aging and discover the full potential of the human body? Global movie star Chris Hemsworth (“Extraction,” “Thor,” “The Avengers”) explores this revolutionary idea in the new National Geographic original series “Limitless with Chris Hemsworth” created by Darren Aronofsky and hailing from his production company Protozoa and Jane Root’s Nutopia.
New scientific research is shattering conventional wisdom about the human body and offers fascinating insights into how we can all unlock our body’s superpowers to fight illness, perform better and even reverse the aging process. This science is put to the test by Hemsworth, who, despite being in peak superhero condition, is on a personal mission to learn how to extend our health, strength and intellect further into our later years.
Undergoing a series of epic trials and extraordinary challenges in order to understand the limits of the human body, he’ll learn firsthand how we can live better for longer by discovering ways to regenerate damage, maximize strength, build resilience, supercharge memory, and confront mortality.
The Astroskin Vital Signs Monitoring Platform, an advanced wearable health monitoring system, is used in the first episode of the series titled Stress-Proof now streaming on Disney +.
Ever since his teenage years, stress has been part of Chris’ life, and he wants to learn how to deal with it better. In this episode of the series, Chris Hemsworth will learn powerful physical and psychological techniques that can be used to control the stress in our lives and combat the risk it poses to long-term health.
The actor takes on the challenge to stay calm during a terrifying walk along a crane that’s projecting out from the roof of a skyscraper. We follow him practicing his walk in VR. Chris is supported during his training by Dr. Modupe Akinola who interprets the actor's physiological response measured with the Astroskin.
During the episode, we also follow Chris Hemsworth wearing the Astroskin during the chilling walk on the crane at the top of a 900-foot-tall skyscraper.
Limitless with Chris Hemsworth is streaming on Disney+.